Skip to content

SUBSCRIBER ONLY

Health |
Biden administration’s limit on drug industry middlemen backfires, pharmacists say

A person in a pharmacist's coat holds a bottle.
The Biden administration’s limit on drug industry middlemen backfires, pharmacists say. (Dreamstime/TNS)
UPDATED:

PBMs, or pharmacy benefit managers, sit at the center of the U.S. supply chain for drugs, where they say they negotiate lower prices for insurers — including Medicare — and for employers and their workers.

Subscribe to continue reading this article.

Already subscribed? To login in, click here.

Originally Published: